Evidence map›Paper›PMID 37035389›Full record

ArticleHeliyon2023

Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.

Xiao-Bo Wang, Tao Luo, Shao-Long Lu, Hua-Ze Lu, Tai-Yun Zhao, Zhi-Jun Jiang, Xin-Yu Liu, Chang Zhao, Le-Qun Li, Jie Chen

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiao-Bo WangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Tao LuoDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Shao-Long LuDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Hua-Ze LuDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Tai-Yun ZhaoGuangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning, China.
Zhi-Jun JiangDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Xin-Yu LiuDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Chang ZhaoDepartment of Interventional Therapy, Guangxi Medical University Cancer Hospital, Nanning, China.
Le-Qun LiDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Jie ChenDepartment of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence has manifested that circular RNAs (circRNAs) exhibited critical function in regulating various signaling pathways related to hepatocellular carcinoma (HCC) recurrence. However, the role and mechanism of the circRNAs in the HCC early recurrence remain elusive. In this study, high-throughput RNA-sequencing (RNA-seq) analysis was conducted to identify the expression profile of circRNAs in HCC tissues and circ_0005218 was identified as one circRNA that significantly up-regulated in early recurrent HCC tissues. And patients with high expression of circ_0005218 showed worsen overall survival (OS) and disease-free survival (DFS). Moreover, the promotion effects of circ_0005218 on HCC cells in term of proliferation, invasion and metastasis were confirmed both in vitro and vivo by gain- and loss-of function assays. In addition, dual-luciferase reporter assays showed that circ_0005218 could competitively bind to micro-RNA (miR)-31-5p. Furthermore, we showed that suppression of CDK1 by miR-31-5p could be partially rescued by up-regulating circ_0005218. Taken together, the present study indicates that circ_0005218 absorbed miR-31-5p as a sponge to weaken its suppression on CDK1 expression, and thus boost HCC cell invasion and migration, which would act as a potential biomarker to predict the HCC early recurrence and as a new therapeutic target for treatment of HCC.

Indexed as

CDK1circ_0005218Early recurrenceHepatocellular carcinomamiR-31-5p

Identifiers

PMID37035389
PMCPMC10073894
OpenAlexW4353051716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.